Seqera Publishes State of the Workflow 2024 Community Survey Results
July 16 2024 - 9:46AM
Business Wire
Fourth annual report highlights bioinformatics
and scientific computing trends and challenges experienced by the
Nextflow ecosystem
Seqera, the leading platform for scientific data analysis in the
life sciences space and creator of Nextflow, recently published the
results of its fourth annual State of the Workflow survey measuring
trends in workflow management for bioinformatics and scientific
computing. Most notably, this report highlights industry shifts in
attitudes toward open science, a first glance at the pivotal role
open science is already playing to advance scientific
knowledge.
The fourth annual survey was the first to ask the prominent
Nextflow community about their perspective around open science and
its role in their research. A clear majority (about 82 percent of
respondents) stated that open science is already fundamental to
their research.
“Our most recent State of the Workflow results make it clear
that open science is already making a significant impact on the
scientific community,” said Evan Floden, CEO and co-founder of
Seqera. “Supporting researchers by providing them with
best-in-class open source software has been the driver behind
everything that we do at Seqera. We’re enthusiastic about the
progress we’re seeing in the open science space and its adoption
among researchers in life sciences, from biotech to academia, and
beyond, and expect to see this number continue to grow.”
The commitment to open science among Nextflow users highlights
not just its immediate benefits, but also reflects a broader
cultural shift in how scientific research is conducted. By
prioritizing transparency and collaboration, the community is
driving innovations that are more reproducible and verifiable.
Additionally, the 2024 report benchmarks cloud adoption among
bioinformaticians, spotlighting challenges related to the
complexities of today’s expansive scientific data, and presents
current user preferences for workflow management across different
sectors of scientific research.
Some key findings of the 2024 report include:
- Bioinformatics analyses are increasingly moving to public
cloud, driven by fast adoption among for-profit companies.
Nearly 60% of respondents still use high-performance computing
clusters, but 73% of biotech firms now favor public cloud for
better scalability and flexibility.
- As the industry scales its workflows, multi-cloud
deployments are on the rise to enhance performance and flexibility
needs. By 2024, 14% of cloud batch service users were running
workloads in two clouds, and 4% in three clouds, reflecting the
growing trend toward leveraging multiple cloud providers for
optimized performance, cost efficiency, and improved security.
- Open Science is fundamental to advancing science for
everyone. Open Science enhances collaboration, efficiency, and
cost-effectiveness, with 63% of users seeing time savings and 42%
recognizing financial benefits. This commitment reflects a cultural
shift toward more transparent and reproducible scientific
research.
By sharing these trends, Seqera aims to equip researchers,
developers, and organizations with the knowledge needed to leverage
Nextflow effectively, fostering innovation and collaboration within
the bioinformatics community.
This report is based on a survey conducted in May 2024 among
Seqera’s Nextflow community and nf-core channels, which received
608 responses. The 2024 survey results and prior annual survey
results can be found on the Seqera blog:
https://seqera.io/blog/.
About Seqera
Seqera makes complex data analysis accessible at any scale by
providing the tools to drive innovation in genomics, global health,
and beyond. The company provides software for scientists solving
today’s most complex and important challenges from pioneering
innovative therapeutics to unveiling the secrets of our universe.
The journey began a decade ago with Nextflow, their flagship open
software that helps over 100,000 global scientists conduct science
faster, on larger datasets, and with more confidence and
flexibility than ever before. Today, Seqera consolidates fragmented
data and diverse computing resources into a unified platform. Their
modern biotech stack is trusted by 150 leading life sciences
organizations including AstraZeneca, Roche, and Johnson &
Johnson.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240716846902/en/
Media Contact Matter Communications for Seqera
seqera@matternow.com